Search

Your search keyword '"Schoenland, Stefan"' showing total 158 results
Start Over Author "Schoenland, Stefan"
158 results on '"Schoenland, Stefan"'

1. Systemic Light Chain Amyloidosis

Author

Minnema, Monique, Schönland, Stefan, Sureda, Anna, editor, Corbacioglu, Selim, editor, Greco, Raffaella, editor, Kröger, Nicolaus, editor, and Carreras, Enric, editor

Published
2024
Full Text
View/download PDF

2. Healthcare Resource Utilization and Cost-of-Illness in Systemic Light Chain (AL) Amyloidosis in Europe: Results From the Real-World, Retrospective EMN23 Study

Author

Jaccard, Arnaud, Bridoux, Frank, Roeloffzen, Wilfried, Minnema, Monique C., Bergantim, Rui, Hájek, Roman, João, Cristina, Cibeira, M. Teresa, Palladini, Giovanni, Schönland, Stefan, Merlini, Giampaolo, Milani, Paolo, Dimopoulos, Meletios A., Ravichandran, Sriram, Hegenbart, Ute, Agis, Hermine, Gros, Blanca, Asra, Aisha, Magarotto, Valeria, Cheliotis, Giorgos, Psarros, Giorgos, Sonneveld, Pieter, Wechalekar, Ashutosh, and Kastritis, Efstathios

Published
2024
Full Text
View/download PDF

3. Birtamimab plus standard of care in light-chain amyloidosis: the phase 3 randomized placebo-controlled VITAL trial

Author

Gertz, Morie A., Cohen, Adam D., Comenzo, Raymond L., Kastritis, Efstathios, Landau, Heather J., Libby, Edward N., Liedtke, Michaela, Sanchorawala, Vaishali, Schönland, Stefan, Wechalekar, Ashutosh, Zonder, Jeffrey A., Palladini, Giovanni, Walling, Jackie, Guthrie, Spencer, Nie, Christie, Karp, Carol, Jin, Yuying, Kinney, Gene G., and Merlini, Giampaolo

Published
2023
Full Text
View/download PDF

4. Amyloidose

Author

Hagmeyer, Lars, Hegenbart, Ute, Schönland, Stefan, Kleibrink, Björn, Teschler, Helmut, Kreuter, Michael, editor, Costabel, Ulrich, editor, Herth, Felix JF, editor, and Kirsten, Detlef, editor

Published
2022
Full Text
View/download PDF

5. Long-Term Results of Allogeneic Stem Cell Transplantation in Adult Ph- Negative High-Risk Acute Lymphoblastic Leukemia

Author

Beelen, Dietrich W., Arnold, Renate, Stelljes, Matthias, Alakel, Nael, Brecht, Arne, Bug, Gesine, Bunjes, Donald, Faul, Christoph, Finke, Jürgen, Franke, Georg-Nikolaus, Holler, Ernst, Kobbe, Guido, Kröger, Nicolaus, Rösler, Wolf, Scheid, Christof, Schönland, Stefan, Stadler, Michael, Tischer, Johanna, Wagner-Drouet, Eva, Wendelin, Knut, Brüggemann, Monika, Reiser, Lena, Hoelzer, Dieter, and Gökbuget, Nicola

Published
2022
Full Text
View/download PDF

7. Outcomes of Haploidentical Transplantation in Patients with Relapsed Multiple Myeloma: An EBMT/CIBMTR Report

Author

Sahebi, Firoozeh, Garderet, Laurent, Kanate, Abraham S, Eikema, Diderik-Jan, Knelange, Nina Simone, Alvelo, Omar F Dávila, Koc, Yener, Blaise, Didier, Bashir, Qaiser, Moraleda, José M, Dreger, Peter, Sanchez, James F, Ciurea, Stefan, Schouten, Harry, Shah, Nirav N, Verbeek, Mareike, Rösler, Wolf, Diez-Martin, Jose L, Schoenland, Stefan, D'Souza, Anita, Kröger, Nicolaus, and Hari, Parameswaran

Subjects
Biomedical and Clinical Sciences, Cardiovascular Medicine and Haematology, Regenerative Medicine, Stem Cell Research, Clinical Trials and Supportive Activities, Transplantation, Clinical Research, Hematology, Rare Diseases, Cancer, Good Health and Well Being, Adult, Aged, Allografts, Disease-Free Survival, Female, Follow-Up Studies, Graft vs Host Disease, Hematopoietic Stem Cell Transplantation, Humans, Incidence, Male, Middle Aged, Multiple Myeloma, Recurrence, Retrospective Studies, Risk Factors, Survival Rate, Allogeneic hematopoietic cell transplantation, Haploidentical, Multiple myeloma, Clinical Sciences, Immunology, Cardiovascular medicine and haematology
Abstract

Allogeneic hematopoietic cell transplantation (allo-HCT) using siblings and matched donors has the potential for long-term disease control in a subset of high-risk patients with multiple myeloma (MM); however, the data on using haploidentical donors in this disease are limited. We conducted a retrospective analysis to examine the outcomes of patients with MM who underwent haploidentical allo-HCT within European Society for Blood and Marrow Transplantation/Center for International Blood and Marrow Transplant Research centers. A total of 96 patients underwent haploidentical allo-HCT between 2008 and 2016. With a median follow-up of 24.0 months (range, 13.2 to 24.9 months), 97% (95% confidence interval [CI], 93% to 100%) of patients had neutrophil engraftment by day 28, and 75% (95% CI, 66% to 84%) achieved platelet recovery by day 60. Two-year progression-free survival (PFS) was 17% (95% CI, 8% to 26%), and overall survival (OS) was 48% (95% CI, 36% to 59%). At 2 years, the cumulative risk of relapse/progression was 56% (95% CI, 45% to 67%), and 1-year nonrelapse mortality (NRM) was 21% (95% CI, 13% to 29%). The incidences of acute graft-versus-host-disease (GVHD) grades II-IV by 100 days and chronic GVHD at 2 years were 39% (95% CI, 28% to 49%) and 46% (95% CI, 34% to 59%), respectively. On univariate analysis, use of post-transplantation cyclophosphamide (PT-Cy) (54% [95% CI, 41% to 68%] versus 25% [95% CI, 1% to 48%]; P =.009) and use of bone marrow as source of stem cells (72% [95% CI, 55% to 89%] versus 31% [95% CI, 17% to 46%]; P = .001) were associated with improved OS at 2 years. Disease status, patient sex, intensity of conditioning regimen, recipient/donor sex mismatch, and cytomegalovirus serostatus had no impact on OS, PFS, or NRM. Haploidentical transplantation is feasible for patients with multiply relapsed or high-risk MM, with an encouraging 2-year OS of 48% and an NRM of 21% at 1 year, supporting further investigation of haploidentical allo-HCT in suitable candidates with MM.

Published
2019

9. Search for AL amyloidosis risk factors using Mendelian randomization

Author

Saunders, Charlie N., Chattopadhyay, Subhayan, Huhn, Stefanie, Weinhold, Niels, Hoffmann, Per, Nöthen, Markus M., Jöckel, Karl-Heinz, Schmidt, Börge, Landi, Stefano, Goldschmidt, Hartmut, Milani, Paolo, Merlini, Giampaolo, Rowcieno, Dorota, Hawkins, Philip, Hegenbart, Ute, Palladini, Giovanni, Wechalekar, Ashutosh, Schönland, Stefan O., Försti, Asta, Houlston, Richard, and Hemminki, Kari

Published
2021
Full Text
View/download PDF

12. Tandem Autologous Stem Cell Transplantation Improves Outcomes in Newly Diagnosed Multiple Myeloma with Extramedullary Disease and High-Risk Cytogenetics: A Study from the Chronic Malignancies Working Party of the European Society for Blood and Marrow Transplantation

Author

Gagelmann, Nico, Eikema, Diderik-Jan, Koster, Linda, Caillot, Denis, Pioltelli, Pietro, Lleonart, Juan Bargay, Reményi, Péter, Blaise, Didier, Schaap, Nicolaas, Trneny, Marek, Passweg, Jakob, Porras, Rocio Parody, Cahn, Jean Yves, Musso, Maurizio, Poiré, Xavier, Fenk, Roland, Itälä-Remes, Maija, Pavone, Vincenzo, Fouillard, Loic, Maertens, Johan, Bron, Dominique, Pouli, Anastasia, Schroyens, Wilfried, Schönland, Stefan, Garderet, Laurent, Yakoub-Agha, Ibrahim, and Kröger, Nicolaus

Published
2019
Full Text
View/download PDF

14. Outcome of a Salvage Third Autologous Stem Cell Transplantation in Multiple Myeloma

Author

Garderet, Laurent, Iacobelli, Simona, Koster, Linda, Goldschmidt, Hartmut, Johansson, Jan-Erik, Bourhis, Jean Henri, Krejci, Marta, Leleu, Xavier, Potter, Michael, Blaise, Didier, Koenecke, Christian, Peschel, Christian, Radocha, Jakub, Metzner, Bernd, Lenain, Pascal, Schäfer-Eckart, Kerstin, Pohlreich, David, Grasso, Mariella, Caillot, Denis, Einsele, Herman, Ladetto, Marco, Schönland, Stefan, and Kröger, Nicolaus

Published
2018
Full Text
View/download PDF

15. Incidence of Second Primary Malignancies after Autologous Transplantation for Multiple Myeloma in the Era of Novel Agents

Author

Sahebi, Firoozeh, Iacobelli, Simona, Sbianchi, Giulia, Koster, Linda, Blaise, Didier, Reményi, Péter, Russell, Nigel H., Ljungman, Per, Kobbe, Guido, Apperley, Jane, Trneny, Marek, Krejci, Marta, Wiktor-Jedrzejczak, Wieslaw, Sanchez, James F., Schaap, Nicolaas, Isaksson, Cecilia, Lenhoff, Stig, Browne, Paul, Scheid, Christof, Wilson, Keith M.O., Yakoub-Agha, Ibrahim, Muñiz, Soledad González, Schönland, Stefan, Morris, Curly, Garderet, Laurent, and Kröger, Nicolaus

Published
2018
Full Text
View/download PDF

18. Baseline Characteristics Predicting Very Good Outcome of Allogeneic Hematopoietic Cell Transplantation in Young Patients With High Cytogenetic Risk Chronic Lymphocytic Leukemia - A Retrospective Analysis From the Chronic Malignancies Working Party of the EBMT

Author

van Gelder, Michel, Ziagkos, Dimitris, de Wreede, Liesbeth, van Biezen, Anja, Dreger, Peter, Gramatzki, Martin, Stelljes, Matthias, Andersen, Niels Smedegaard, Schaap, Nicolaas, Vitek, Antonin, Beelen, Dietrich, Lindström, Vesa, Finke, Jürgen, Passweg, Jacob, Eder, Matthias, Machaczka, Maciej, Delgado, Julio, Krüger, William, Raida, Luděk, Socié, Gerard, Jindra, Pavel, Afanasyev, Boris, Wagner, Eva, Chalandon, Yves, Henseler, Anja, Schoenland, Stefan, Kröger, Nicolaus, and Schetelig, Johannes

Published
2017
Full Text
View/download PDF

21. Post-Transplantation Cyclophosphamide for Graft-versus- Host Disease Prophylaxis in Multiple Myeloma Patients Who Underwent Allogeneic Hematopoietic Cell Transplantation: First Comparison by Donor Type. A Study from the Chronic Malignancies Working Party of the European Society for Blood and Marrow Transplantation

Author

Sahebi, Firoozeh, Eikema, Dirk-Jan, Koster, Linda, Kroger, Nicolaus, Meijer, Ellen, van Doesum, Jaap A., Rovira, Montserrat, Koc, Yener, Angelucci, Emanuele, Blaise, Didier, Sammassimo, Simona, McDonald, Andrew, Arroyo, Concepcion Herrera, Sanchez, James F., Forcade, Edouard, Castagna, Luca, Stölzel, Friedrich, Sanz, Jaime, Tischer, Johanna, Ciceri, Fabio, Valcarcel, David, Proia, Anna, Hayden, Patrick J., Beksac, Meral, Yakoub-Agha, Ibrahim, and Schönland, Stefan

Published
2021
Full Text
View/download PDF

26. Complications of Autologous Stem Cell Transplantation in Multiple Myeloma: Results from the CALM Study

Author

Waszczuk-Gajda, Anna, primary, Penack, Olaf, additional, Sbianchi, Giulia, additional, Koster, Linda, additional, Blaise, Didier, additional, Reményi, Péter, additional, Russell, Nigel, additional, Ljungman, Per, additional, Trneny, Marek, additional, Mayer, Jiri, additional, Iacobelli, Simona, additional, Kobbe, Guido, additional, Scheid, Christof, additional, Apperley, Jane, additional, Touzeau, Cyrille, additional, Lenhoff, Stig, additional, Jantunen, Esa, additional, Anagnostopoulos, Achilles, additional, Paris, Laura, additional, Browne, Paul, additional, Thieblemont, Catherine, additional, Schaap, Nicolaas, additional, Sierra, Jorge, additional, Yakoub-Agha, Ibrahim, additional, Garderet, Laurent, additional, Styczynski, Jan, additional, Schoemans, Helene, additional, Moiseev, Ivan, additional, Duarte, Rafael F., additional, Peric, Zinaida, additional, Montoto, Silvia, additional, van Biezen, Anja, additional, Mikulska, Malgorzata, additional, Aljurf, Mahmoud, additional, Ruutu, Tapani, additional, Kröger, Nicolaus, additional, Morris, Curly, additional, Koenecke, Christian, additional, Schoenland, Stefan, additional, and Basak, Grzegorz W., additional

Published
2022
Full Text
View/download PDF

28. International Differences in Baseline Characteristics and Practice Patterns in Patients with NEWLY Diagnosed Multiple Myeloma Undergoing Upfront Autologous STEM Cell Transplantation

Author

Garderet, Laurent, Gras, Luuk, Koster, Linda, D'Souza, Anita, Estrada-Merly, Noel, Hari, Parameswaran, Saber, Wael, Cowan, Andrew J, Iida, Minako, Okamoto, Shinichiro, Takamatsu, Hiroyuki, Mizuno, Shohei, Kawamura, Koji, Kodera, Yoshihisa, Hamad, Nada, Ko, Bor-Sheng, Liam, Christopher, Ho, Kim Wah, Sim Goh, A, Keat Tan, S, Elhaddad, Alaa M., Bazarbachi, Ali, Chaudhry, Qamar un Nisa, Alfar, Rozan, Bekadja, Mohamed-Amine, Benakli, Malek, Frutos Ortiz, Cristobal Augusto, Riva, Eloisa, Galeano, Sebastian, Bass, Francisca, Mian, Hira S, McCurdy, Arleigh, Wang, Feng Rong, Neumann, Daniel, Koh, Mickey, Snowden, John A, Schönland, Stefan, McLornan, Donal P., Hayden, Patrick John, Sureda, Anna, Greinix, Hildegard T., Aljurf, Mahmoud, Atsuta, Yoshiko, and Niederwieser, Dietger

Published
2022
Full Text
View/download PDF

29. Worldwide Network for Blood and Marrow Transplantation (WBMT) Global Study on Baseline Characteristics and Clinical Outcomes in NEWLY Diagnosed Multiple Myeloma Patients Undergoing Upfront Autologous STEM Cell Transplantation, a Study Off 61,725 Patients from 629 Centers

Author

Garderet, Laurent, Gras, Luuk, Koster, Linda, D'Souza, Anita, Estrada-Merly, Noel, Hari, Parameswaran, Saber, Wael, Cowan, Andrew J., Iida, Minako, Okamoto, Shinichiro, Takamatsu, Hiroyuki, Mizuno, Shohei, Kawamura, Koji, Kodera, Yoshihisa, Hamad, Nada, Ko, Bor-Sheng, Liam, Christopher, HO, KIM Wah, Sim Goh, A., Keat Tan, S., Elhaddad, Alaa M., Bazarbachi, Ali, Chaudhry, Qamar un Nisa, Alfar, Rozan, Bekadja, Mohamed-Amine, Benakli, Malek, Frutos Ortiz, Cristobal Augusto, Riva, Eloisa, Galeano, Sebastian, Bass, Francisca, Mian, Hira S., McCurdy, Arleigh, Wang, Feng Rong, Neumann, Daniel, Koh, Mickey, Snowden, John A., Schönland, Stefan, McLornan, Donal P., Hayden, Patrick John, Sureda, Anna, Greinix, Hildegard T., Aljurf, Mahmoud, Atsuta, Yoshiko, and Niederwieser, Dietger

Published
2022
Full Text
View/download PDF

30. Autologous Peripheral Blood Stem Cell Mobilisation Techniques, Stem Cell Yields and Practice Variation-By-Country in Patients with Myeloma Undergoing First Autologous Stem Cell Transplants in EBMT Centres between 2012 and 2021

Author

Hayden, Patrick John, Eikema, Dirk-Jan, Koster, Linda, Snowden, John A, Caillot, Denis, Van Gorkom, Gwendolyn, Griskevicius, Laimonas, Arcese, William, Crawley, Charles, Musso, Maurizio, Bulabois, Claude-Eric, Martin, Alexander M, Netelenbos, Tanja, McDonald, Andrew, Maertens, Johan, Parma, Matteo, Illes, Arpad, Isaksson, Cecilia, Sossa, Claudia, Drozd-Sokolowska, Joanna, Raj, Kavita, Beksac, Meral, Schönland, Stefan, McLornan, Donal P., and Yakoub-Agha, Ibrahim

Published
2022
Full Text
View/download PDF

31. Efficacy and Safety of Belantamab Mafodotin Monotherapy in Patients with Relapsed or Refractory Light Chain Amyloidosis: A Phase 2 Study By the European Myeloma Network

Author

Kastritis, Efstathios, Palladini, Giovanni, Dimopoulos, Meletios-Athanasios, Jaccard, Arnaud, Merlini, Giampaolo, Theodorakakou, Foteini, Fotiou, Despina, Minnema, Monique C., Wechalekar, Ashutosh D., Varghese, Sreeja, Manousou, Kyriaki, Sonneveld, Pieter, and Schönland, Stefan

Published
2022
Full Text
View/download PDF

32. Autologous/reduced-intensity allogeneic stem cell transplantation vs autologous transplantation in multiple myeloma: long-term results of the EBMT-NMAM2000 study

Author

Gahrton, Gösta, Iacobelli, Simona, Björkstrand, Bo, Hegenbart, Ute, Gruber, Astrid, Greinix, Hildegard, Volin, Liisa, Narni, Franco, Carella, Angelo Michele, Beksac, Meral, Bosi, Alberto, Milone, Giuseppe, Corradini, Paolo, Schönland, Stefan, Friberg, Kristina, van Biezen, Anja, Goldschmidt, Hartmut, de Witte, Theo, Morris, Curly, Niederwieser, Dietger, Garderet, Laurent, and Kröger, Nicolaus

Published
2013
Full Text
View/download PDF

33. A randomized phase 3 study of ixazomib-dexamethasone versus physician's choice in relapsed or refractory AL amyloidosis

Author

Dispenzieri, Angela Kastritis, Efstathios Wechalekar, Ashutosh D. Schoenland, Stefan O. Kim, Kihyun Sanchorawala, Vaishali and Landau, Heather J. Kwok, Fiona Suzuki, Kenshi Comenzo, Raymond L. Berg, Deborah Liu, Guohui Kumar, Arun Faller, Douglas V. Merlini, Giampaolo

Abstract

In the first phase 3 study in relapsed/refractory AL amyloidosis (TOURMALINE-AL1 NCT01659658), 168 patients with relapsed/refractory AL amyloidosis after 1-2 prior lines were randomized to ixazomib (4 mg, days 1, 8, 15) plus dexamethasone (20 mg, days 1, 8, 15, 22; n = 85) or physician’s choice (dexamethasone +/- melphalan, cyclophosphamide, thalidomide, or lenalidomide; n = 83) in 28-day cycles until progression or toxicity. Primary endpoints were hematologic response rate and 2-year vital organ deterioration or mortality rate. Only the first primary endpoint was formally tested at this interim analysis. Best hematologic response rate was 53% with ixazomib-dexamethasone vs 51% with physician’s choice (p = 0.76). Complete response rate was 26 vs 18% (p = 0.22). Median time to vital organ deterioration or mortality was 34.8 vs 26.1 months (hazard ratio 0.53; 95% CI, 0.32-0.87; p = 0.01). Median treatment duration was 11.7 vs 5.0 months. Adverse events of clinical importance included diarrhea (34 vs 30%), rash (33 vs 20%), cardiac arrhythmias (26 vs 15%), nausea (24 vs 14%). Despite not meeting the first primary endpoint, all time-to-event data favored ixazomib-dexamethasone. These results are clinically relevant to this relapsed/refractory patient population with no approved treatment options.

Published
2022

35. A Novel Early Relapse Prediction Score Based on Age, ISS and Disease Status at the Time of Transplant in Patients with Newly Diagnosed Multiple Myeloma. a Study of the EBMT Chronic Malignancies Working Party

Author

Beksac, Meral, primary, Iacobelli, Simona, additional, Koster, Linda, additional, Blaise, Didier, additional, Cornelissen, Jan J., additional, Reményi, Péter, additional, Leleu, Xavier, additional, Gedde-Dahl, Tobias, additional, Poire, Xavier, additional, Griskevicius, Laimonas, additional, Forcade, Edouard, additional, Lenhoff, Stig, additional, Rabin, Neil K, additional, Kobbe, Guido, additional, Netelenbos, Tanja, additional, Arcese, William, additional, Mear, Jean-Baptiste, additional, Engelhardt, Monika, additional, Pabst, Thomas, additional, Schaap, Nicolaas, additional, Sossa, Claudia Lucia, additional, Elmaagacli, Ahmet, additional, Hayden, Patrick John, additional, Schoenland, Stefan, additional, and Yakoub-Agha, Ibrahim, additional

Published
2021
Full Text
View/download PDF

36. Autologous Hematopoietic Cell Transplantation For Relapsed Multiple Myeloma Performed With Stem Cells Re-Mobilised Following A Prior AUTO-HCT - A Retrospective Study on Behalf of EBMT CMWP

Author

Byrne, Jennifer, Snowden, John A., Crawley, Charles, Colorado Araujo, Mercedes, de Wreede, Liesbeth, Passweg, Jakob, Van Gorkom, Gwendolyn, GÜRMAN, GÜNHAN, Zinger, Nienke, Gras, Luuk, Yakoub-Agha, Ibrahim, Schoenland, Stefan, Tilly, Herve, BEKSAÇ, MERAL, Hayden, Patrick, Bulabois, Claude Eric, Arat, Mutlu, Basak, Grzegorz, Pouli, Anastasia, Poire, Xavier, Wilson, Keith M. O., Lioure, Bruno, Schroyens, Wilfried, ÖZKURT, ZÜBEYDE NUR, and Drozd-Sokolowska, Joanna

Published
2021

39. P-076 The impact of heterogeneous disease distribution on MRD detection in patients with relapsed multiple myeloma

Author

John, Lukas, Grözinger, Martin, Sachpekidis, Christos, Huhn, Stefanie, Sester, Lilli, Friedrich, Mirco, Frenking, Jan, Michel, Christian, Kauer, Joseph, Wagner, Barbara, Quick, Sabine, Birgit, Schneiders, Nickel, Ewelina, Schwab, Ricarda, Manta, Calin-Petru, Reichert, Philipp, Schönland, Stefan, Dimitrakopolou-Straus, Antonia, Muller-Tidow, Carsten, Haberkorn, Uwe, Hundemer, Michael, Sauer, Sandra, Raab, Marc, Delorme, Stefan, and Weinhold, Niels

Published
2023
Full Text
View/download PDF

42. Health-Related Quality of Life in Patients with AL Amyloidosis Treated with Daratumumab, Bortezomib, Cyclophosphamide, and Dexamethasone: Results from the Phase 3 Andromeda Study

Author

Sanchorawala, Vaishali, Palladini, Giovanni, Minnema, Monique C., Jaccard, Arnaud, Lee, Hans C., Gibbs, Simon D., Mollee, Peter, Venner, Christopher P., Lu, Jin, Schönland, Stefan, Gatt, Moshe, Suzuki, Kenshi, Kim, Kihyun, Cibeira, M. Teresa, Beksac, Meral, Libby, Edward, Valent, Jason, Hungria, Vania T.M., Wong, Sandy W., Rosenzweig, Michael, Bumma, Naresh, Chauveau, Dominique, Gries, Katharine S., Fastenau, John, Tran, NamPhuong, Qin, Xiang, Vasey, Sandra Y., Tromp, Brenda, Weiss, Brendan M., Vermeulen, Jessica, Merlini, Giampaolo, Comenzo, Raymond L., Kastritis, Efstathios, and Wechalekar, Ashutosh D.

Published
2020
Full Text
View/download PDF

43. Reduction in Absolute Involved Free Light Chain and Difference between Involved and Uninvolved Free Light Chain Is Associated with Prolonged Major Organ Deterioration Progression-Free Survival in Patients with Newly Diagnosed AL Amyloidosis Receiving Bortezomib, Cyclophosphamide, and Dexamethasone with or without Daratumumab: Results from Andromeda

Author

Comenzo, Raymond L., Kastritis, Efstathios, Palladini, Giovanni, Minnema, Monique C., Wechalekar, Ashutosh D., Jaccard, Arnaud, Sanchorawala, Vaishali, Lee, Hans C., Gibbs, Simon D., Mollee, Peter, Venner, Christopher P., Lu, Jin, Schönland, Stefan, Gatt, Moshe, Suzuki, Kenshi, Kim, Kihyun, Cibeira, M. Teresa, Beksac, Meral, Libby, Edward, Valent, Jason, Hungria, Vania T.M., Wong, Sandy W., Rosenzweig, Michael, Bumma, Naresh, Chauveau, Dominique, Dimopoulos, Meletios A, Tran, NamPhuong, Qin, Xiang, Vasey, Sandra Y., Tromp, Brenda, Weiss, Brendan M., Vermeulen, Jessica, and Merlini, Giampaolo

Published
2020
Full Text
View/download PDF

45. Treosulfan Conditioning for Allogeneic Transplantation in Multiple Myeloma – Improved Overall Survival in first line Hematopoietic Stem Cell Transplantation

Author

Gran, Charlotte, primary, Wang, Junfeng, additional, Nahi, Hareth, additional, Koster, linda, additional, Gahrton, Gosta, additional, Wolschke, Christine, additional, Einsele, Hermann, additional, Niittyvoupio, Riitta, additional, Blaise, Didier, additional, Niederwieser, Dietger, additional, Meier, Ellen, additional, Petersen, Eefke, additional, de Wreede, Liesbeth C., additional, Ljungman, Per, additional, Bourhis, Jean Henri, additional, Veelken, Hendrik, additional, Beelen, Dietrich, additional, Stelljes, Matthias, additional, Gerbitz, Armin, additional, Vincent, Laure, additional, Finke, Jurgen, additional, Passweg, Jakob, additional, Milpied, Noel, additional, Stölzel, Friedrich, additional, Yakoub-Agha, Ibrahim, additional, Schoenland, Stefan, additional, Garderet, Laurent, additional, and Kroger, Nicolaus, additional

Published
2019
Full Text
View/download PDF

46. P-277: Carfilzomib, lenalidomide and dexamethasone followed by a second autologous hematopoietic cell transplantation is an effective strategy in first-relapsed multiple myeloma

Author

Tilmont, Remi, Yakoub-Agha, Ibrahim, Eikema, Diderik-Jan, Zinger, Nienke, Haenel, Mathias, Schaap, Nicolaas, Arroyo, Concepcion Herrera, Schuermans, Christine, Bethge, Wolfgang, Engelhardt, Monika, Kuball, Jürgen, Michieli, Mariagrazia, Schub, Natalie, Wilson, Keith M.O., Bourhis, Jean Henri, Mateos, María-Victoria, Rabin, Neil, Jost, Edgar, Kröger, Nicolaus, Moraleda, José Mª, Sica, Simona, Hayden, Patrick J., Beksac, Meral, Schönland, Stefan, and Manier, Salomon

Published
2022
Full Text
View/download PDF

Catalog

Books, media, physical & digital resources
See catalog results